ClearNote Health Launches Early Detection Test for Pancreatic Cancer
The test offers a 76 percent sensitivity to detection of stage 1 and stage 2 pancreatic cancers
Subscribe to Clinical Diagnostics Insider to view
Start a Free Trial for immediate access to this article